Literature DB >> 3019675

Identification of an Epstein-Barr virus-coded thymidine kinase.

E Littler, J Zeuthen, A A McBride, E Trøst Sørensen, K L Powell, J E Walsh-Arrand, J R Arrand.   

Abstract

We have demonstrated the presence of an Epstein-Barr virus (EBV)-coded thymidine kinase (TK) by producing biochemically transformed, TK-positive mammalian cell lines using either microinjection of whole EBV virions or calcium phosphate-mediated transfection of the SalI-B restriction endonuclease fragment of EBV DNA. Analysis of these cell lines showed that: (i) EBV DNA was present in the cell lines, (ii) sequences from the SalI-B restriction endonuclease fragment of EBV were expressed, (iii) a TK activity was present and (iv) a protein with antigenic cross-reactivity with the herpes simplex virus (HSV) TK was produced. The identity of the EBV TK gene was determined by demonstrating that a recombinant plasmid, which expressed the protein product of the BXLF1 open reading frame as a fusion protein, could complement TK- strains of E. coli. A comparison of the predicted amino acid sequences of the TK proteins of EBV and HSV-1 revealed significant regions of homology.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019675      PMCID: PMC1167064          DOI: 10.1002/j.1460-2075.1986.tb04450.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Factors governing expression of the herpes simplex virus gene for thymidine kinase in clonal derivatives of transformed mouse L cells.

Authors:  R Buttyan; P G Spear
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

3.  Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments.

Authors:  J R Arrand; L Rymo; J E Walsh; E Björck; T Lindahl; B E Griffin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

4.  Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.

Authors:  T Dambaugh; C Beisel; M Hummel; W King; S Fennewald; A Cheung; M Heller; N Raab-Traub; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Effects of arabinofuranosylthymine on Epstein-Barr virus replication.

Authors:  T Ooka; A Calender
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

6.  Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA.

Authors:  A Graessmann; H Wolf; G W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

7.  Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization.

Authors:  A K Datta; R J Feighny; J S Pagano
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

8.  Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells.

Authors:  J Roubal; G Klein
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

9.  Characterization of purified Epstein--Barr virus induced deoxyribonucleic acid polymerase: nucleotide turnover, processiveness, and phosphonoacetic acid sensitivity.

Authors:  D Grossberger; W Clough
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

10.  Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.

Authors:  B M Colby; P A Furman; J E Shaw; G B Elion; J S Pagano
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

View more
  31 in total

1.  Conservation of gene organization in the lymphotropic herpesviruses herpesvirus Saimiri and Epstein-Barr virus.

Authors:  U A Gompels; M A Craxton; R W Honess
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

Review 4.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Epstein-Barr virus and virus human protein interaction maps.

Authors:  Michael A Calderwood; Kavitha Venkatesan; Li Xing; Michael R Chase; Alexei Vazquez; Amy M Holthaus; Alexandra E Ewence; Ning Li; Tomoko Hirozane-Kishikawa; David E Hill; Marc Vidal; Elliott Kieff; Eric Johannsen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-19       Impact factor: 11.205

6.  Nucleotide sequence of the thymidine kinase gene of a new strain of herpes simplex virus type 1.

Authors:  G Palu'; M A Biasolo
Journal:  Virus Genes       Date:  1989-03       Impact factor: 2.332

7.  Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus.

Authors:  K Xie; M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.

Authors:  F Wang; A Marchini; E Kieff
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

9.  The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.

Authors:  E A Gustafson; A C Chillemi; D R Sage; J D Fingeroth
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys.

Authors:  S L Martin; D I Aparisio; P K Bandyopadhyay
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.